Evan E. Facer, DO

Washington University in St. Louis School of Medicine

Disclosure(s): AbbVie, Inc: I have no relevant disclosures, but I receive funding from AbbVie, Inc. for characterization of ceftazidime/avibactam use in children.

Poster(s):

• (P-1913) Implementation and Evaluation of a Curriculum on Antimicrobial Stewardship for Pediatric Residents
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET